DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Corbus Pharmaceuticals Q4 EPS $(0.41) Misses $(0.36) Estimate, Sales $2.573M Miss $3.68M Estimate

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.36) by 13.89 percent. This is a 36.67 percent decrease over losses of $(0.3) per

Benzinga · 03/12/2020 11:08

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.36) by 13.89 percent. This is a 36.67 percent decrease over losses of $(0.3) per share from the same period last year. The company reported quarterly sales of $2.573 million which missed the analyst consensus estimate of $3.68 million by 30.08 percent. This is a 33.52 percent increase over sales of $1.927 million the same period last year.